APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nodoame

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nodoame Industry Growth and Trends Forecast to 2032

5 July 2026104 pages

Choose your research edition.

Industry ResearchNodoame Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Nodoame Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Nodoame Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nodoame Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Nodoame Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Nodoame market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nodoame is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nodoame is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nodoame is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nodoame include Comvita, Vocalzone, Good Health, Kanro, UHA Mikakuto Co.,Ltd, RYUKAKUSAN Co.,Ltd., Zirkulin, Ricola and Fisherman's Friend, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nodoame market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nodoame market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nodoame market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nodoame.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nodoame market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nodoame Market by Company

Comvita

Vocalzone

Good Health

Kanro

UHA Mikakuto Co.,Ltd

RYUKAKUSAN Co.,Ltd.

Zirkulin

Ricola

Fisherman's Friend

Golden Throat Holdings Group Company Limited

Nin Jiom

Wong Lo Kat

Poon Goor Soe

Guilin Sanjin Pharmaceutical Company Limited

Nodoame Segment by Type

Medicinal

Food

Nodoame Segment by Application

Supermarket

Drugstore

Nodoame Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nodoame market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nodoame and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nodoame.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nodoame manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nodoame in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Medicinal Table 2. Major Company of Food Table 3. Global Nodoame Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nodoame Sales by Type (2021-2026) & (k units) Table 5. Global Nodoame Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nodoame Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nodoame Sales Market Share in Value by Type (2021-2026) Table 8. Global Nodoame Price by Type (2021-2026) & (USD/unit) Table 9. Global Nodoame Sales by Type (2027-2032) & (k units) Table 10. Global Nodoame Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nodoame Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nodoame Sales Market Share in Value by Type (2027-2032) Table 13. Global Nodoame Price by Type (2027-2032) & (USD/unit) Table 14. North America Nodoame Sales by Type (2021-2026) & (k units) Table 15. North America Nodoame Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nodoame Sales by Type (2021-2026) & (k units) Table 17. Europe Nodoame Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nodoame Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Nodoame Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nodoame Sales by Type (2021-2026) & (k units) Table 21. Latin America Nodoame Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nodoame Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Nodoame Sales by Type (2021-2026) & (US$ Million) Table 24. Nodoame Industry Trends Table 25. Nodoame Industry Drivers Table 26. Nodoame Industry Opportunities and Challenges Table 27. Nodoame Industry Restraints Table 28. Global Nodoame Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nodoame Revenue Market Share by Company (2021-2026) Table 30. Global Nodoame Sales by Company (2021-2026) & (k units) Table 31. Global Nodoame Sales Share by Company (2021-2026) Table 32. Global Nodoame Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Nodoame Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nodoame Major Company Production Sites and Headquarters Table 35. Global Nodoame Company, Product Type & Application Table 36. Global Nodoame Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nodoame by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nodoame Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nodoame Sales by Region (2021-2026) & (k units) Table 41. Global Nodoame Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nodoame Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nodoame Sales Market Share in Value by Region (2021-2026) Table 44. Global Nodoame Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Nodoame Sales by Region (2027-2032) & (k units) Table 46. Global Nodoame Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nodoame Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nodoame Sales Market Share in Value by Region (2027-2032) Table 49. Global Nodoame Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Nodoame Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nodoame Sales by Application (2021-2026) & (k units) Table 52. Global Nodoame Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nodoame Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nodoame Sales Market Share in Value by Application (2021-2026) Table 55. Global Nodoame Price by Application (2021-2026) & (USD/unit) Table 56. Global Nodoame Sales by Application (2027-2032) & (k units) Table 57. Global Nodoame Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nodoame Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nodoame Sales Market Share in Value by Application (2027-2032) Table 60. Global Nodoame Price by Application (2027-2032) & (USD/unit) Table 61. North America Nodoame Sales by Application (2021-2026) & (k units) Table 62. North America Nodoame Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nodoame Sales by Application (2021-2026) & (k units) Table 64. Europe Nodoame Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nodoame Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Nodoame Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nodoame Sales by Application (2021-2026) & (k units) Table 68. Latin America Nodoame Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nodoame Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Nodoame Sales by Application (2021-2026) & (US$ Million) Table 71. Comvita Company Information Table 72. Comvita Business Overview Table 73. Comvita Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Comvita Nodoame Product Portfolio Table 75. Comvita Recent Development Table 76. Vocalzone Company Information Table 77. Vocalzone Business Overview Table 78. Vocalzone Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Vocalzone Nodoame Product Portfolio Table 80. Vocalzone Recent Development Table 81. Good Health Company Information Table 82. Good Health Business Overview Table 83. Good Health Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Good Health Nodoame Product Portfolio Table 85. Good Health Recent Development Table 86. Kanro Company Information Table 87. Kanro Business Overview Table 88. Kanro Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Kanro Nodoame Product Portfolio Table 90. Kanro Recent Development Table 91. UHA Mikakuto Co.,Ltd Company Information Table 92. UHA Mikakuto Co.,Ltd Business Overview Table 93. UHA Mikakuto Co.,Ltd Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. UHA Mikakuto Co.,Ltd Nodoame Product Portfolio Table 95. UHA Mikakuto Co.,Ltd Recent Development Table 96. RYUKAKUSAN Co.,Ltd. Company Information Table 97. RYUKAKUSAN Co.,Ltd. Business Overview Table 98. RYUKAKUSAN Co.,Ltd. Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. RYUKAKUSAN Co.,Ltd. Nodoame Product Portfolio Table 100. RYUKAKUSAN Co.,Ltd. Recent Development Table 101. Zirkulin Company Information Table 102. Zirkulin Business Overview Table 103. Zirkulin Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Zirkulin Nodoame Product Portfolio Table 105. Zirkulin Recent Development Table 106. Ricola Company Information Table 107. Ricola Business Overview Table 108. Ricola Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Ricola Nodoame Product Portfolio Table 110. Ricola Recent Development Table 111. Fisherman's Friend Company Information Table 112. Fisherman's Friend Business Overview Table 113. Fisherman's Friend Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Fisherman's Friend Nodoame Product Portfolio Table 115. Fisherman's Friend Recent Development Table 116. Golden Throat Holdings Group Company Limited Company Information Table 117. Golden Throat Holdings Group Company Limited Business Overview Table 118. Golden Throat Holdings Group Company Limited Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Golden Throat Holdings Group Company Limited Nodoame Product Portfolio Table 120. Golden Throat Holdings Group Company Limited Recent Development Table 121. Nin Jiom Company Information Table 122. Nin Jiom Business Overview Table 123. Nin Jiom Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Nin Jiom Nodoame Product Portfolio Table 125. Nin Jiom Recent Development Table 126. Wong Lo Kat Company Information Table 127. Wong Lo Kat Business Overview Table 128. Wong Lo Kat Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Wong Lo Kat Nodoame Product Portfolio Table 130. Wong Lo Kat Recent Development Table 131. Poon Goor Soe Company Information Table 132. Poon Goor Soe Business Overview Table 133. Poon Goor Soe Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Poon Goor Soe Nodoame Product Portfolio Table 135. Poon Goor Soe Recent Development Table 136. Guilin Sanjin Pharmaceutical Company Limited Company Information Table 137. Guilin Sanjin Pharmaceutical Company Limited Business Overview Table 138. Guilin Sanjin Pharmaceutical Company Limited Nodoame Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Guilin Sanjin Pharmaceutical Company Limited Nodoame Product Portfolio Table 140. Guilin Sanjin Pharmaceutical Company Limited Recent Development Table 141. North America Nodoame Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. North America Nodoame Sales by Country (2021-2026) & (k units) Table 143. North America Nodoame Sales Market Share by Country (2021-2026) Table 144. North America Nodoame Sales Forecast by Country (2027-2032) & (k units) Table 145. North America Nodoame Sales Market Share Forecast by Country (2027-2032) Table 146. North America Nodoame Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Nodoame Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Nodoame Market Share by Country (2021-2026) Table 149. North America Nodoame Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Nodoame Market Share Forecast by Country (2027-2032) Table 151. Europe Nodoame Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Europe Nodoame Sales by Country (2021-2026) & (k units) Table 153. Europe Nodoame Sales Market Share by Country (2021-2026) Table 154. Europe Nodoame Sales Forecast by Country (2027-2032) & (k units) Table 155. Europe Nodoame Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Nodoame Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Nodoame Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Nodoame Market Share by Country (2021-2026) Table 159. Europe Nodoame Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Nodoame Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Nodoame Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Nodoame Sales by Country (2021-2026) & (k units) Table 163. Asia-Pacific Nodoame Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Nodoame Sales Forecast by Country (2027-2032) & (k units) Table 165. Asia-Pacific Nodoame Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Nodoame Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Nodoame Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Nodoame Market Share by Country (2021-2026) Table 169. Asia-Pacific Nodoame Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Nodoame Market Share Forecast by Country (2027-2032) Table 171. Latin America Nodoame Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Latin America Nodoame Sales by Country (2021-2026) & (k units) Table 173. Latin America Nodoame Sales Market Share by Country (2021-2026) Table 174. Latin America Nodoame Sales Forecast by Country (2027-2032) & (k units) Table 175. Latin America Nodoame Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Nodoame Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Nodoame Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Nodoame Market Share by Country (2021-2026) Table 179. Latin America Nodoame Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Nodoame Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Nodoame Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Nodoame Sales by Country (2021-2026) & (k units) Table 183. Middle East and Africa Nodoame Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Nodoame Sales Forecast by Country (2027-2032) & (k units) Table 185. Middle East and Africa Nodoame Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Nodoame Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Nodoame Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Nodoame Market Share by Country (2021-2026) Table 189. Middle East and Africa Nodoame Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Nodoame Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Nodoame Distributors List Table 194. Nodoame Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Nodoame Image Figure 2. Global Nodoame Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nodoame Market Size (2021-2032) & (US$ Million) Figure 4. Global Nodoame Sales (2021-2032) & (k units) Figure 5. Medicinal Image Figure 6. Global Medicinal Sales YoY Growth (2021-2032) & (k units) Figure 7. Food Image Figure 8. Global Food Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Nodoame Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nodoame Market Share by Type 2025 VS 2032 Figure 11. North America Nodoame Sales Market Share in Volume by Type in 2025 Figure 12. North America Nodoame Sales Market Share in Value by Type in 2025 Figure 13. Europe Nodoame Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nodoame Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nodoame Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nodoame Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nodoame Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nodoame Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nodoame Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nodoame Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nodoame Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Supermarket Image Figure 24. Global Supermarket Sales YoY Growth (2021-2032) & (k units) Figure 25. Drugstore Image Figure 26. Global Drugstore Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Nodoame Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Nodoame Market Share by Application 2025 VS 2032 Figure 29. North America Nodoame Sales Market Share in Volume by Application in 2025 Figure 30. North America Nodoame Sales Market Share in Value by Application in 2025 Figure 31. Europe Nodoame Sales Market Share in Volume by Application in 2025 Figure 32. Europe Nodoame Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Nodoame Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Nodoame Sales Market Share in Value by Application in 2025 Figure 35. Latin America Nodoame Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Nodoame Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Nodoame Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Nodoame Sales Market Share in Value by Application in 2025 Figure 39. North America Nodoame Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Nodoame Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Nodoame Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Nodoame Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Nodoame Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Nodoame Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Nodoame Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Nodoame Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Nodoame Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Nodoame Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Nodoame Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Nodoame Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Nodoame Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Nodoame Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nodoame Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Nodoame Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Nodoame Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Nodoame Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Nodoame Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Nodoame Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Nodoame Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Nodoame Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Medicinal
  • Food
Applications
  • Supermarket
  • Drugstore
Companies covered
  • Comvita
  • Vocalzone
  • Good Health
  • Kanro
  • UHA Mikakuto Co.,Ltd
  • RYUKAKUSAN Co.,Ltd.
  • Zirkulin
  • Ricola
  • Fisherman's Friend
  • Golden Throat Holdings Group Company Limited
  • Nin Jiom
  • Wong Lo Kat
  • Poon Goor Soe
  • Guilin Sanjin Pharmaceutical Company Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nodoame Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nodoame Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nodoame Market by Type
  6. 1.3.1 Medicinal
  7. 1.3.2 Food
  8. 1.4 Global Nodoame Market Size by Type
  9. 1.4.1 Global Nodoame Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nodoame Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nodoame Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nodoame Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nodoame Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nodoame Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nodoame Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nodoame Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nodoame Industry Trends
  2. 2.2 Nodoame Industry Drivers
  3. 2.3 Nodoame Industry Opportunities and Challenges
  4. 2.4 Nodoame Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nodoame Revenue (2021-2026)
  2. 3.2 Global Top Players by Nodoame Sales (2021-2026)
  3. 3.3 Global Top Players by Nodoame Price (2021-2026)
  4. 3.4 Global Nodoame Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nodoame Major Company Production Sites & Headquarters
  6. 3.6 Global Nodoame Company, Product Type & Application
  7. 3.7 Global Nodoame Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nodoame Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nodoame Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nodoame Tier 1, Tier 2, and Tier 3
4 Nodoame Regional Status and Outlook
  1. 4.1 Global Nodoame Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nodoame Historic Market Size by Region
  3. 4.2.1 Global Nodoame Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nodoame Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nodoame Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nodoame Forecasted Market Size by Region
  7. 4.3.1 Global Nodoame Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nodoame Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nodoame Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nodoame by Application
  1. 5.1 Nodoame Market by Application
  2. 5.1.1 Supermarket
  3. 5.1.2 Drugstore
  4. 5.2 Global Nodoame Market Size by Application
  5. 5.2.1 Global Nodoame Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Nodoame Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Nodoame Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Nodoame Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Nodoame Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Nodoame Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Nodoame Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Nodoame Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Comvita
  2. 6.1.1 Comvita Company Information
  3. 6.1.2 Comvita Business Overview
  4. 6.1.3 Comvita Nodoame Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Comvita Nodoame Product Portfolio
  6. 6.1.5 Comvita Recent Developments
  7. 6.2 Vocalzone
  8. 6.2.1 Vocalzone Company Information
  9. 6.2.2 Vocalzone Business Overview
  10. 6.2.3 Vocalzone Nodoame Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Vocalzone Nodoame Product Portfolio
  12. 6.2.5 Vocalzone Recent Developments
  13. 6.3 Good Health
  14. 6.3.1 Good Health Company Information
  15. 6.3.2 Good Health Business Overview
  16. 6.3.3 Good Health Nodoame Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Good Health Nodoame Product Portfolio
  18. 6.3.5 Good Health Recent Developments
  19. 6.4 Kanro
  20. 6.4.1 Kanro Company Information
  21. 6.4.2 Kanro Business Overview
  22. 6.4.3 Kanro Nodoame Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kanro Nodoame Product Portfolio
  24. 6.4.5 Kanro Recent Developments
  25. 6.5 UHA Mikakuto Co.,Ltd
  26. 6.5.1 UHA Mikakuto Co.,Ltd Company Information
  27. 6.5.2 UHA Mikakuto Co.,Ltd Business Overview
  28. 6.5.3 UHA Mikakuto Co.,Ltd Nodoame Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 UHA Mikakuto Co.,Ltd Nodoame Product Portfolio
  30. 6.5.5 UHA Mikakuto Co.,Ltd Recent Developments
  31. 6.6 RYUKAKUSAN Co.,Ltd.
  32. 6.6.1 RYUKAKUSAN Co.,Ltd. Company Information
  33. 6.6.2 RYUKAKUSAN Co.,Ltd. Business Overview
  34. 6.6.3 RYUKAKUSAN Co.,Ltd. Nodoame Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 RYUKAKUSAN Co.,Ltd. Nodoame Product Portfolio
  36. 6.6.5 RYUKAKUSAN Co.,Ltd. Recent Developments
  37. 6.7 Zirkulin
  38. 6.7.1 Zirkulin Company Information
  39. 6.7.2 Zirkulin Business Overview
  40. 6.7.3 Zirkulin Nodoame Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zirkulin Nodoame Product Portfolio
  42. 6.7.5 Zirkulin Recent Developments
  43. 6.8 Ricola
  44. 6.8.1 Ricola Company Information
  45. 6.8.2 Ricola Business Overview
  46. 6.8.3 Ricola Nodoame Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ricola Nodoame Product Portfolio
  48. 6.8.5 Ricola Recent Developments
  49. 6.9 Fisherman's Friend
  50. 6.9.1 Fisherman's Friend Company Information
  51. 6.9.2 Fisherman's Friend Business Overview
  52. 6.9.3 Fisherman's Friend Nodoame Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Fisherman's Friend Nodoame Product Portfolio
  54. 6.9.5 Fisherman's Friend Recent Developments
  55. 6.10 Golden Throat Holdings Group Company Limited
  56. 6.10.1 Golden Throat Holdings Group Company Limited Company Information
  57. 6.10.2 Golden Throat Holdings Group Company Limited Business Overview
  58. 6.10.3 Golden Throat Holdings Group Company Limited Nodoame Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Golden Throat Holdings Group Company Limited Nodoame Product Portfolio
  60. 6.10.5 Golden Throat Holdings Group Company Limited Recent Developments
  61. 6.11 Nin Jiom
  62. 6.11.1 Nin Jiom Company Information
  63. 6.11.2 Nin Jiom Business Overview
  64. 6.11.3 Nin Jiom Nodoame Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Nin Jiom Nodoame Product Portfolio
  66. 6.11.5 Nin Jiom Recent Developments
  67. 6.12 Wong Lo Kat
  68. 6.12.1 Wong Lo Kat Company Information
  69. 6.12.2 Wong Lo Kat Business Overview
  70. 6.12.3 Wong Lo Kat Nodoame Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Wong Lo Kat Nodoame Product Portfolio
  72. 6.12.5 Wong Lo Kat Recent Developments
  73. 6.13 Poon Goor Soe
  74. 6.13.1 Poon Goor Soe Company Information
  75. 6.13.2 Poon Goor Soe Business Overview
  76. 6.13.3 Poon Goor Soe Nodoame Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Poon Goor Soe Nodoame Product Portfolio
  78. 6.13.5 Poon Goor Soe Recent Developments
  79. 6.14 Guilin Sanjin Pharmaceutical Company Limited
  80. 6.14.1 Guilin Sanjin Pharmaceutical Company Limited Company Information
  81. 6.14.2 Guilin Sanjin Pharmaceutical Company Limited Business Overview
  82. 6.14.3 Guilin Sanjin Pharmaceutical Company Limited Nodoame Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Guilin Sanjin Pharmaceutical Company Limited Nodoame Product Portfolio
  84. 6.14.5 Guilin Sanjin Pharmaceutical Company Limited Recent Developments
7 North America by Country
  1. 7.1 North America Nodoame Sales by Country
  2. 7.1.1 North America Nodoame Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nodoame Sales by Country (2021-2026)
  4. 7.1.3 North America Nodoame Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nodoame Market Size by Country
  6. 7.2.1 North America Nodoame Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nodoame Market Size by Country (2021-2026)
  8. 7.2.3 North America Nodoame Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nodoame Sales by Country
  2. 8.1.1 Europe Nodoame Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nodoame Sales by Country (2021-2026)
  4. 8.1.3 Europe Nodoame Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nodoame Market Size by Country
  6. 8.2.1 Europe Nodoame Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nodoame Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nodoame Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nodoame Sales by Country
  2. 9.1.1 Asia-Pacific Nodoame Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nodoame Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nodoame Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nodoame Market Size by Country
  6. 9.2.1 Asia-Pacific Nodoame Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nodoame Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nodoame Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nodoame Sales by Country
  2. 10.1.1 South America Nodoame Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nodoame Sales by Country (2021-2026)
  4. 10.1.3 South America Nodoame Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nodoame Market Size by Country
  6. 10.2.1 South America Nodoame Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nodoame Market Size by Country (2021-2026)
  8. 10.2.3 South America Nodoame Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nodoame Sales by Country
  2. 11.1.1 Middle East and Africa Nodoame Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nodoame Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nodoame Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nodoame Market Size by Country
  6. 11.2.1 Middle East and Africa Nodoame Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nodoame Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nodoame Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nodoame Value Chain Analysis
  2. 12.1.1 Nodoame Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nodoame Production Mode & Process
  7. 12.2 Nodoame Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nodoame Distributors
  10. 12.2.3 Nodoame Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst